Stockreport

Gilead's Coronavirus Drug Is 'Likely Approvable' On Positive Data: Analyst [Investor's Business Daily]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF Related news Gilead Sciences ( GILD ) said Wednesday its experimental coronavirus treatment succeeded in a Phase 2 study — prodding GILD stock to surge in premarket tra [Read more]